Phase 3 Parkinson's Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
A Study of Buntanetap in Participants With PD
Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Parkinson's Disease
Hoffmann-La Roche900 enrolled101 locationsNCT07174310
Recruiting
Phase 3
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Parkinson's Disease (PD)Freezing of GaitFreezing of Gait Symptoms in Parkinson Disease
Radboud University Medical Center60 enrolled1 locationNCT07316296
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
Parkinson's Disease
Jiangsu HengRui Medicine Co., Ltd.450 enrolled1 locationNCT06596876
Recruiting
Phase 3
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
Parkinson's Disease
Tanta University66 enrolled1 locationNCT05576818
Not Yet Recruiting
Phase 2Phase 3
Investigating the effect of Rasagiline on freezing of gait in Parkinson’s disease using accelerometry and functional MRI.
Freezing of gait in Parkinson's disease
A/Prof Simon Lewis40 enrolled1 locationACTRN12614000355673
Recruiting
Phase 3
The treatment of depression in Parkinson's Disease using mifepristone.
Diagnostic and Statistical Manual 4th edition (DSM-IV) Major Depressive Episode in patients with Parkinson's Disease.
Neurological Foundation20 enrolled1 locationACTRN12606000253505